Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort. Hewison C, Khan U, Bastard M, Lachenal N, et al. Clin Infect Dis 2022;75:1006-1013.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hewison C, Khan U, Bastard M, Lachenal N, et al. Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort. Clin Infect Dis 2022;75:1006-1013.
PMID: 35028659